Event Brief
Samsung Biologics acquires GSK's U.S. facility
Filed: Mar 31, 2026 at 11:07 PM ET
Summary: Samsung Biologics has completed the acquisition of GSK's U.S. facility for $280 million.
WHO: Samsung Biologics
WHAT: acquires GSK's U.S. facility
WHEN: Mar 31, 2026 at 10:46 PM ET
WHERE: USA
WHY: Reason not stated in article.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →